首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein
Authors:Larry M Gordon  Andy B Lee  Piotr Ruchala  Alan J Waring  Patrick W Mobley
Institution:a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA
b Department of Biological Sciences, California State Polytechnic University, Pomona, CA, USA
c Chemistry Department, California State Polytechnic University, Pomona, 3801 West Temple Avenue, Pomona CA 91768, USA
d Department of Medicine, UCLA School of Medicine, Los Angeles, CA, USA
Abstract:Given their high alanine and glycine levels, plaque formation, α-helix to β-sheet interconversion and fusogenicity, FP (i.e., the N-terminal fusion peptide of HIV-1 gp41; 23 residues) and amyloids were proposed as belonging to the same protein superfamily. Here, we further test whether FP may exhibit ‘amyloid-like’ characteristics, by contrasting its structural and functional properties with those of Aβ(26-42), a 17-residue peptide from the C-terminus of the amyloid-beta protein responsible for Alzheimer's. FTIR spectroscopy, electron microscopy, light scattering and predicted amyloid structure aggregation (PASTA) indicated that aqueous FP and Aβ(26-42) formed similar networked β-sheet fibrils, although the FP fibril interactions were weaker. FP and Aβ(26-42) both lysed and aggregated human erythrocytes, with the hemolysis-onsets correlated with the conversion of α-helix to β-sheet for each peptide in liposomes. Congo red (CR), a marker of amyloid plaques in situ, similarly inhibited either FP- or Aβ(26-42)-induced hemolysis, and surface plasmon resonance indicated that this may be due to direct CR-peptide binding. These findings suggest that membrane-bound β-sheets of FP may contribute to the cytopathicity of HIV in vivo through an amyloid-type mechanism, and support the classification of HIV-1 FP as an ‘amyloid homolog’ (or ‘amylog’).
Keywords:HIV-1  Human Immunodeficiency Virus  Type 1  HIV-2  Human Immunodeficiency Virus  Type 2  gp41  glycoprotein 41  000 of HIV-1  FP  fusion peptide (23-residues) at the N-terminus of HIV-1 gp41 (LAV1a strain)  SIV  simian immunodeficiency virus  gp32  glycoprotein 32  000 of HIV-2/SIV    amyloid-beta protein  Aβ(1-40) or Aβ(1-42)  amyloid-beta protein residues 1-40 or 1-42  Aβ(26-42)  C-terminal peptide 26-42 of amyloid-beta protein  DLS  dynamic light scattering  TEM  transmission electron microscopy  PIRA  parallel β-sheet  in register arrangement  PASTA  prediction of amyloid structure aggregation  PBS  phosphate-buffered saline  Phosphate buffer  10   mM sodium phosphate buffer  pH 7  4  HBS-EP buffer  10   mM Hepes  pH 7  4  150   mM NaCl    mM EDTA  0  005%  surfactant P20  DMSO  dimethyl sulfoxide  HFIP  hexafluoroisopropanol  SDS  sodium dodecyl sulfate  TFE  trifluoroethanol  RBC  red blood cells  POPG  1-palmitoyl-2-oleoyl phosphatidylglycerol  LUV  large unilamellar vesicles  POPC  1-palmitoyl-2-oleoylphosphatidylcholine  POPG  1-palmitoyl-2-oleoylphosphatidylglycerol  P/L  peptide/lipid molar ratio  CD  circular dichroism  FTIR  Fourier transform infrared  ATR  attenuated-total-reflectance  2D-NMR  two dimensional Nuclear Magnetic Resonance  IR50  inhibitory ratio (IR) of the agent concentration to that the membrane-active agent that induces 50% inhibition  IR100  inhibitory ratio (IR) of the agent concentration to that the membrane-active agent that induces 100% inhibition  ID50  inhibitor concentration that yields 50% inhibition for a stated dose of membrane-active agent  PrP  prion protein  HPrP  human prion protein  BPrP  bovine prion protein  MD  molecular dynamics  SPR  surface plasmon resonance  CR  Congo red
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号